What the FDA labels say about taking them together
Olodaterol and salmeterol
Olodaterol's FDA label of January 3, 2025 names salmeterol in its warnings and precautions section; the salmeterol label PlainMeds reads does not name olodaterol. The olodaterol label: “A 28-week, placebo-controlled US study comparing the safety of another LABA (salmeterol) with placebo, each added to usual asthma therapy, showed an increase in asthma-related deaths in patients receiving salmeterol …”
Check it at the source: the olodaterol FDA label on DailyMed (effective January 3, 2025, Boehringer Ingelheim Pharmaceuticals, Inc.); the salmeterol FDA label on DailyMed (effective October 10, 2022, GlaxoSmithKline LLC).
What does the olodaterol label say about salmeterol?
Olodaterol label, warnings and precautionsA 28-week, placebo-controlled US study comparing the safety of another LABA (salmeterol) with placebo, each added to usual asthma therapy, showed an increase in asthma-related deaths in patients receiving salmeterol (13/13,176 in patients treated with salmeterol vs. 3/13,179 in patients treated with placebo;
Source: FDA drug label (Striverdi Respimat), Boehringer Ingelheim Pharmaceuticals, Inc., effective January 3, 2025 (SPL set 5d9a5433-857e-44ea-b3d6-2a400ca0cef5), via openFDA; the full label on DailyMed
What does the salmeterol label say about olodaterol?
Salmeterol's label (effective October 10, 2022) does not name olodaterol in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (SEREVENT DISKUS), GlaxoSmithKline LLC, effective October 10, 2022 (SPL set 12d9728e-6b5c-4aee-bfb0-745e542ed2e4), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Olodaterol | Salmeterol | |
|---|---|---|
| Labeled for | COPD | Asthma, COPD |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $65.94 per gram Striverdi respimat inhal spray | $6.74 per unit 50 mcg |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once